Company Purple Biotech Ltd

Equities

PPBT

IL0007650166

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly revenue - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:31:09 2024-05-02 am EDT			5-day change	1st Jan Change
20 ^ILa	-10.31%		-0.50%	-37.30%

Apr. 25	Purple Biotech Ltd.'s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting	CI
Mar. 14	Purple Biotech Reports Preclinical Proof of Concept for Its Tribody Platform Technology	CI

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Number of employees: 20

Managers	Title	Age	Since
Gil Efron CEO	Chief Executive Officer	57	18-10-10
Lior Fhima DFI	Director of Finance/CFO	-	22-11-01
Ido Morpurgo COO	Chief Operating Officer	51	20-07-31
Hadas Reuveni CTO	Chief Tech/Sci/R&D Officer	56	16-12-31
Bertrand C. Liang CTO	Chief Tech/Sci/R&D Officer	61	20-01-08
Isaac Israel BRD	Director/Board Member	44	12-09-30
Simcha Rock BRD	Director/Board Member	73	13-07-10
Yisrael Gewirtz AUD	Comptroller/Controller/Auditor	47	16-06-30
William Berlin PRN	Corporate Officer/Principal	-	-
Michael Schickler LAW	General Counsel	55	19-12-31

Members of the board	Title	Age	Since
Eric Rowinsky CHM	Chairman	67	19-10-01
Yael Margolin BRD	Director/Board Member	70	Dec. 19
Simcha Rock BRD	Director/Board Member	73	13-07-10
Ido Agmon BRD	Director/Board Member	46	16-06-26
Robert Gagnon BRD	Director/Board Member	49	21-03-02
Suzana Nahum Zilberberg BRD	Director/Board Member	53	21-05-18
Isaac Israel BRD	Director/Board Member	44	12-09-30
Ori Hershkovitz BRD	Director/Board Member	49	21-12-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	259,905,127	258,842,627 ( 99.59 %)	0	99.59 %

Name	Equities	%	Valuation
Jason Carrick 4.056 %	10,520,000	4.056 %	706 418 ILa
KSM Mutual Funds Ltd. 0.1415 %	367,133	0.1415 %	24 653 ILa
Migdal Mutual Funds Ltd. 0.0875 %	226,876	0.0875 %	15 235 ILa

Name	Equities	%	Valuation
Armistice Capital LLC 9.635 %	2,499,384	9.635 %	2 M ILa
Armistice Capital LLC 7.256 %	1,882,173	7.256 %	1 M ILa
6 Dimensions Capital 0.7484 %	194,139	0.7484 %	130 073 ILa
Kingswood Wealth Advisors LLC 0.7174 %	186,100	0.7174 %	124 687 ILa
Morgan Stanley Capital Services LLC 0.3335 %	86,513	0.3335 %	57 964 ILa
Venture Visionary Partners LLC 0.0600 %	15,553	0.0600 %	10 421 ILa
Wealth Advisors of Iowa LLC 0.0550 %	14,270	0.0550 %	9 561 ILa
XTX Topco Ltd. 0.0523 %	13,561	0.0523 %	9 086 ILa
Geode Capital Management LLC 0.0488 %	12,666	0.0488 %	8 486 ILa
Citadel Securities GP LLC 0.0454 %	11,777	0.0454 %	7 891 ILa

Purple Biotech Ltd.

Science Park 4 Oppenheimer Street

7670104, Rehovot

+972 3 933 3121

http://ww.purple-biotech.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
PURPLE BIOTECH LTD	-37.30%	15.51M
VERTEX PHARMACEUTICALS INCORPORATED	-1.67%	104B
REGENERON PHARMACEUTICALS, INC.	+6.79%	97.47B
ARGENX SE	+5.71%	22.25B
BIONTECH SE	-12.58%	21.68B
GENMAB A/S	-9.70%	18.2B
WUXI APPTEC CO., LTD.	-39.98%	17.02B
BEIGENE, LTD.	-10.14%	16.36B
NEUROCRINE BIOSCIENCES, INC.	+6.99%	14.39B
SAREPTA THERAPEUTICS, INC.	+36.79%	12.37B

Bio Therapeutic Drugs